BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Arthritis
,
Hippocampus
,
Neocentromeres
,
Vitamin E
,
rs2300478
,
ERBB2
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
positive regulation of early endosome to late endosome transport
(biogroup)
Summary
General Info
Body Atlas
Most Correlated Tissues
Microglial cell
Kidney medulla
Kidney cortex
Fetal brain
Omental adipose tissue
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Pyloric ulcer
Caseating tuberculoid granuloma
Duchenne muscular dystrophy
Cutaneous acariasis
Disorder of pregnancy
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Benzothiazoles
niguldipine
desloratadine
GRN protein, human
YM 201636
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
MAST4
TBC1D23
CRADD
HPS1
LCP2
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Microvesicles and exosomes released from cultured H9 embryonic stem cells
L1000 CMAP - Hepatocellular carcinoma HEPG2 cells treated with small molecule perturbagens
L1000 CMAP - Breast carcinoma BT20 cells treated with small molecule perturbagens
L1000 CMAP - Breast cancer MCF7 cells treated with small molecule perturbagens (1 of 4)
L1000 CMAP - Prostate cancer LNCAP cells treated with small molecule perturbagens
Explore Curated Studies Results
Literature
Most Relevant Literature
There were no matches for positive regulation of early endosome to late endosome transport
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Biomarker for Mucolipidosis Disorder Type I, II, III, IV (BioML)
Nilotinib in Huntington's Disease
sCD163 in ALS Patients
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ